Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-24 4:33 pm Purchase | 2025-09-22 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 184,044 3.800% | 3,425 (+1.90%) | Filing History |
| 2025-07-01 4:30 pm Purchase | 2025-06-27 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 180,619 5.200% | 20,707 (+12.95%) | Filing History |
| 2024-12-20 4:30 pm Purchase | 2024-12-18 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 159,912 6.800% | 15,216 (+10.52%) | Filing History |
| 2024-08-23 4:06 pm Purchase | 2024-08-22 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 144,696 8.600% | 412 (+0.29%) | Filing History |
| 2024-02-16 4:32 pm Purchase | 2023-11-20 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 144,284 10.200% | 3,707 (+2.64%) | Filing History |
| 2023-05-05 4:30 pm Purchase | 2023-04-25 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 140,577 13.500% | 16,634 (+13.42%) | Filing History |